Evy Vandemeulebroucke

Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes

Bart Keymeulen, Evy Vandemeulebroucke, Anette G. Ziegler et al. · New England Journal of Medicine · 2005 · 1.1K citations · Full text

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass

Bart Keymeulen, Melanie Walter, Chantal Mathieu et al. · Diabetologia · 2010 · 310 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +12

Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graft

Bart Keymeulen, Pieter Gillard, Chantal Mathieu et al. · Proceedings of the National Academy of Sciences · 2006 · 173 citations · Full text

IA-2 autoantibodies predict impending Type I diabetes in siblings of patients

Katelijn Decochez, I. De Leeuw, Bart Keymeulen et al. · Diabetologia · 2002 · 94 citations · Full text

Metabolic Syndrome, Autoimmune Disease, Autoantibody Production +9

Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients

Bart Keymeulen, Sophie Candon, Samira Fafi‐Kremer et al. · Blood · 2009 · 82 citations · Full text